The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies - Takeaways - MDSpire

The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies

  • By

  • Ming Fan

  • Haiming Kou

  • Liang V. Tang

  • July 14, 2026

Share

  • 1

    Approximately 95% of the population shows evidence of Epstein-Barr virus (EBV) infection during their lifetime.

  • 2

    EBV can lead to aggressive lymphoproliferative disorders, particularly affecting T cells and natural killer (NK) cells.

  • 3

    EBV-positive T/NK-cell disorders include chronic active EBV infection, nasal-type NK/T-cell lymphoma, and aggressive NK-cell leukemia.

  • 4

    Molecular mechanisms of EBV involve viral proteins like LMP1, LMP2A, and EBNA1, which contribute to immune evasion and cell transformation.

  • 5

    High-sensitivity detection methods for EBV may improve classification of T/NK-cell lymphoproliferative disorders and identify underrecognized viral persistence.

Original Source(s)

The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies

  • by Ming Fan, Haiming Kou, Liang V. Tang

  • July 14, 2026

Related Content

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report

Sentara opens 1st stand-alone vascular care center in Hampton Roads

New outpatient center in Norfolk brings faster, more convenient vascular care to dialysis and chemotherapy patients across the region.

  • by

  • July 13, 2026

  • 3 min
Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report